Fig. 1: Proportion of ART initiation and death among PLHIV in China 2017–2019. | Nature Communications

Fig. 1: Proportion of ART initiation and death among PLHIV in China 2017–2019.

From: Associations of modern initial antiretroviral therapy regimens with all-cause mortality in people living with HIV in resource-limited settings: a retrospective multicenter cohort study in China

Fig. 1

Proportion of ART initiation (a) and death (b) among PLHIV in China 2017–2019, stratified by initial ART regimen, ART antiretroviral therapy, NVP nevirapine, EFV efavirenz, DTG dolutegravir, LPV lopinavir, Others= darunavir, raltegravie, elvitegravir and rilpivirine.

Back to article page